ALYSSA HILL: Open Payments
NPI 1265056642 · KINSTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,447 in 66 payments from 28 companies in 2025. Trend: 2023 $802 · 2024 $825 · 2025 $1,447
Food & beverage: $1,447
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 3 | $178 |
| Novartis Pharmaceuticals Corporation | 7 | $143 |
| PFIZER INC. | 6 | $111 |
| Merck Sharp & Dohme LLC | 4 | $107 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| E.R. Squibb & Sons, L.L.C. | 4 | $64 |
| Eisai Inc. | 3 | $61 |
| ARRAY BIOPHARMA INC | 3 | $58 |
| ABBVIE INC. | 3 | $54 |
| Aveo Pharmaceuticals, Inc. | 2 | $54 |
Products named: OPDIVO, KEYTRUDA, Lenvima, OJJAARA, KISQALI, FOTIVDA, Nubeqa, SCEMBLIX.
Industry payments across NC — which companies pay providers there.
